Production of stable bispecific IgG1 by controlled Fab-arm exchange: Scalability from bench to large-scale manufacturing by application of standard approaches

The manufacturing of bispecific antibodies can be challenging for a variety of reasons. For example, protein expression problems, stability issues, or the use of non-standard approaches for manufacturing can result in poor yield or poor facility fit. In this paper, we demonstrate the use of standard...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gramer, Michael J, van den Bremer, Ewald TJ, van Kampen, Muriel D, Kundu, Amitava, Kopfmann, Peter, Etter, Eric, Stinehelfer, David, Long, Justin, Lannom, Tom, Noordergraaf, Esther H, Gerritsen, Jolanda, Labrijn, Aran F, Schuurman, Janine, van Berkel, Patrick HC, Parren, Paul WHI
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2013
Sujets:
Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896610/
https://ncbi.nlm.nih.gov/pubmed/23995617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.26233
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires